CIO

APRIL 17, 2024

While this example offers a peek at how productivity gains can be achieved in software development, what’s even more interesting is how tech companies, including Planview, are jockeying for competitive advantage in what they bring to market. The new sequences are then tested at the VTT lab by using E.

Biotech 721

Biotech Banking Retail Innovation 721

Alpha Sense BI

FEBRUARY 8, 2023

Attracting industry leaders, emerging fast-growth companies, and technology creators from around the world, life science corporations share their latest advances, leading research, and best practices — as well as their intentions to scale their digital health solutions — to the masses in hopes of securing capital.

Biotech 96

Biotech Research Innovation Capital 96

Alpha Sense BI

MAY 28, 2024

Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial market intelligence to gain a competitive advantage in the shifting landscape. Want to learn about how AlphaSense is empowering venture capital firms to accelerate their research efforts?

Capital 69

Capital Startups Biotech Due Diligence 69

Netbasequid

FEBRUARY 22, 2021

In their paper on Deep Tech: The Great Wave of Innovation , BCG and Hello Tomorrow explain “what deep tech is, how it works, how different stakeholders can contribute to it, and how it can be harnessed for competitive advantage.” And they used NetBase Quid to inform their research. From here, the biotech world is your oyster.

Biotech 98

Biotech Innovation Intellectual Property Market Research 98

Alpha Sense BI

AUGUST 30, 2023

As time goes on and more firms adopt AI tools, these capabilities will become even more essential to maintain a competitive advantage. Research shows that the AI in asset management market will grow at a staggering 34% CAGR through 2027.

Management 98

Management Biotech Due Diligence Algorithm 98

Alpha Sense BI

JANUARY 25, 2023

Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.

Biotech 96

Biotech Pharmaceutical Hospitals Market Intelligence 96

Alpha Sense BI

APRIL 12, 2024

Expert interviews are a critical primary research tool that financial professionals often leverage to complete their investment process with last-mile, experiential insights. That expert call may be one of the single advantages in the stack. Similarly, expert calls fill particular roles.

Primary Research 52

Primary Research Advantage Advantage Research 52